Luke Walker - Insider Trading & Ownership

Location
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA
Summary
The estimated net worth of Luke Walker is at least $186K dollars as of June 18, 2025. Luke Walker is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $186K.
Signature
/s/ Andrea Paul, attorney-in-fact for Luke Walker
All Insider Reports
All Insider Reports

Ownership of Luke Walker

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. Director $186K +$25K +15.5% Jun 17, 2025
HARP Harpoon Therapeutics, Inc. Chief Medical Officer $0 Mar 11, 2024
CNTX Context Therapeutics Inc. Director Jun 12, 2025

Insider Transactions Reported by Luke Walker:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.